Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2016

Derivative Instruments (Tables) [Abstract]

Impact of derivative instruments on the statement of operations and OCI

		September 30, 2016		December 31, 2015
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars	$	900,000	$	1,175,000
Denominated in Pounds Sterling	£	550,000	£	550,000
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars	$	250,000	$	250,000
Denominated in Pounds Sterling	£	1,050,000	£	1,050,000
Derivatives designated as cash flow hedges:
Denominated in U.S. Dollars	$	57,000	$	57,000
Denominated in Canadian Dollars	$	72,000	$	72,000
Denominated in Pounds Sterling	£	63,000	£	60,000
Derivative instruments not designated:
Denominated in Canadian Dollars	$	37,000	$	47,000
Denominated in Pounds Sterling	£	20,100	£	-

		Three Months Ended				Nine Months Ended
		September 30,				September 30,
	Location		2016		2015		2016		2015
Gain (loss) on forward exchange contracts recognized in income	Interest expense	$	3,420	$	2,347	$	4,789	$	6,285
Loss (gain) on option exercise(1)	Loss (gain) on derivatives, net		-		-		-		(58,427)
(Gain) on release of cumulative translation adjustment related to ineffectiveness on net investment hedge	Loss (gain) on derivatives, net		(2,516)		-		(2,516)		-
Gain (loss) on foreign exchange contracts and term loans designated as net investment hedge recognized in OCI	OCI		53,421		174,239		229,256		208,854
(1) In April 2011, we completed the acquisition of substantially all of the real estate assets of privately-owned Genesis Healthcare Corporation. In conjunction with this transaction, we received the option to acquire an ownership interest in Genesis Healthcare. In February 2015, Genesis Healthcare closed on a transaction to merge with Skilled Healthcare Group to become a publicly traded company which required us to record the value of the derivative asset due to the net settlement feature.